Largely garnered from studies in laboratory animals, the ventral pallidum (VP) is recognized as an integrator of sensory, emotional, and cognitive information with appropriate motoric responses. These functional complexities are reflected in behaviors associated with pain experiences, reward-motivated function, stress, social interaction and affiliation. With the increased resolution of modernday human brain imaging technology, preclinical studies are being substantiated, and the role of the VP in the human emotional repertoire and psychiatric disorders is being clarified.
Several clinical reports point to VP involvement in disorders of motivation. For example, single-photon emission computed tomography of Parkinson's Disease (PD) patients with pathological gambling show enhanced resting state activity (regional cerebral blood flow) in the VP of these individuals compared with non-gambling PD patients (Cilia et al, 2008) .
Functional magnetic resonance imaging can assess rapid responses of the brain to 'unseen' reward cues or cues that are recognized outside our awareness. Presentation of unseen cues for natural and drug-related rewards (Childress et al, 2008) , or monetary rewards (Pessiglione et al, 2007) , results in rapid activation of the VP before conscious recognition. These rapid responses also predict the positive affect responses to the same stimuli when presented in a visible manner, suggesting that the affective/ motivational processes within and outside awareness are continuous and regulated by the VP (Childress et al, 2008) .
Another behavior with high emotional valence is social affiliation, for example, pair bonding. Both the formation and the maintenance of pair bonding are associated with VP activation (assessed with structural magnetic resonance imaging and positron emission tomography) in non-human primates (Bales et al, 2007) . It follows that a dysregulation of the VP and its limbic circuit may contribute to disorders of social bonding such as autism.
Positron emission tomography with receptor-selective radiotracers adds neurochemical assessments to studies on neuroanatomical substrates regulating emotional states. For example, increases in negative affect ratings by healthy human volunteers who are associated with sustained sadness (Zubieta et al, 2003) or sustained muscle pain (Zubieta et al, 2002) correlate with deactivation of m-opioid receptors in the VP. By inference, these findings indicate that positive affect is regulated by activated m-opioid receptors in the VP.
The imaging literature converges to indicate that VP transmission is involved in the emotional overlays of motivated behaviors. This interpretation is substantiated by preclinical studies on m-opioid receptors in the VP, wherein these receptors are capable of inducing a profound and enduring plasticity (Mickiewicz et al, 2009 ). Future laboratory and clinical studies will aid in fully appreciating the role of the VP in emotional processing and motivated behaviors, and the psychiatric consequence of its dysregulation. ............................................................................................................................................................ www.neuropsychopharmacology.org information in the central nervous system. In addition, this brain region sends and receives projections from the mesolimbic dopamine system so often implicated in addiction (Bannerman et al, 2004) . Further, the hippocampus has been directly implicated in addiction behavior (Vorel et al, 2001 ), likely because of the fact that there is increasing evidence suggesting that drug addiction represents a conditioning phenomenon that is largely dependent on associations between drug effects and environmental cues (Berke and Hyman, 2000) .
Coordinated hippocampal/accumbal regulation is likely at the heart of the protective addiction phenotype produced by environmental enrichment. We find that rats reared in an enriched condition (large cages with cohorts and novel objects) self-administer cocaine or amphetamine less readily than rats in the isolated control group (Green et al, 2009) . This protective phenotype is likely mediated by a coordinated decrease in cAMP response element binding protein (CREB) activity in the accumbens coupled with an increase in the hippocampus. Further, CREB has been linked to neuronal excitability (Dong et al, 2006) , suggesting that some yet to be identified CREB target gene may produce this protective phenotype by decreasing excitability in the accumbens and increasing excitability in the hippocampus.
Addiction-related molecular targets in the hippocampus are also being interrogated using proteomics approaches. It is known that exposure to drugs of abuse alters the expression of certain synaptic proteins. Indeed, a recent study uses this state-of-the-art technology to examine the effects of morphine administration on the protein expression profile at hippocampal synapses (Moron et al, 2007) . This study finds that repeated morphine administration alters the synaptic distribution of endocytic proteins. This finding has functional implications, as receptor trafficking largely depends on endocytosis, and therefore morphine may alter receptor localization by affecting synaptic redistribution of the endocytic machinery. The idea that endocytic proteins, such as clathrin, may be involved in morphine-induced changes at hippocampal synapses is quite innovative and opens up a new direction for the study of the mechanisms underlying morphine-induced neuroadaptations. In addition, these findings suggest that the study of hippocampal neuroadaptations induced by repeated morphine treatment has great potential to reveal the mechanisms contributing to the development of opiate addiction.
Addiction is a complex polygenic psychiatric condition involving many brain regions, proteins and physiological effects, not to mention varied etiologies. Understanding the molecular mechanisms underlying addictive behavior will someday allow for therapeutic intervention that will be both efficacious and safe.
